Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Create Alert
Watchlist
Gland Pharma
₹1,794.80
0.00 (0.00%)
1D
Manage alerts
Active alerts for Gland Pharma
ADD NEW ALERT
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
BSE .
12 hours ago
Gland Pharma CEO Shyamakant Giri resigns, effective April 30, 2026. Board acknowledges his leadership; resignation letter attached with SEBI compliance.
BSE .
13 hours ago
Gland Pharma's ESOP Committee approved 1,626 stock options under ESOP 2025 for one employee. Options priced at INR 897.40 and INR 1 will vest gradually over three years from March 2027.
Capital Market .
2 weeks ago
Gland Pharma appoints Dr. Jitendra Gangwal as VP R&D, effective 18 Feb 2026.
Business Standard .
4 weeks ago
Gland Pharma secures USFDA approval for Zoledronic Acid Injection. The approved ANDA covers a 4 mg/100 mL single-dose bag formulation.
ScoutQuest .
4 weeks ago
Gland Pharma gains USFDA nod for Zoledronic Acid Injection, treating hypercalcemia, myeloma, and bone metastases. US sales of this drug were USD 6.7M for 12 months ending Nov 2025.
BSE .
1 month ago
Gland Pharma announces schedule for analyst and investor meetings in Feb 2026. Meetings include NDR with Motilal Oswal, JM Financial, Systematix, and Axis Capital events.
BSE .
1 month ago
Gland Pharma COO Satnam Singh Loomba to retire on March 31, 2026, upon superannuation. The company appreciates his contributions; he has been with Gland Pharma since May 2024.
ScoutQuest .
1 month ago
Gland Pharma shares surged nearly 7% post Q3 results.
Capital Market .
1 month ago
Gland Pharma surged 28.6x in volume, rising 7.1% to Rs.1,810.1 on NSE. ABB India rose 9.4% to Rs.5,516; Gillette India up 4.5% to Rs.8,223 on volume spikes.
ScoutQuest .
1 month ago
Gland Pharma plans Rs.2,000 crore CapEx over 5 years to expand BFS lines. The company targets 15% CAGR growth with ophthalmic segment focus.